NLH Fundamental Analysis - NOVA LEAP HEALTH CORP

Fundamental Rating

Taking everything into account, NLH scores 4 out of 10 in our fundamental rating. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of NLH get a neutral evaluation. Nothing too spectacular is happening here. NLH has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NLH has reported negative net income.

In the past year NLH had a positive cash flow from operations.

In multiple years NLH reported negative net income over the last 5 years.

NLH had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of NLH (0.49%) is comparable to the rest of the industry.

NLH has a Return On Equity of 0.62%. This is in the better half of the industry: NLH outperforms 66.67% of its industry peers.

The Return On Invested Capital of NLH (3.34%) is better than 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.49%
ROE	0.62%
ROIC	3.34%

ROA(3y)-0.79%

ROA(5y)2.27%

ROE(3y)-0.91%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NLH has a Profit Margin (0.41%) which is comparable to the rest of the industry.

In the last couple of years the Profit Margin of NLH has declined.

Looking at the Operating Margin, with a value of 3.04%, NLH is in line with its industry, outperforming 60.00% of the companies in the same industry.

The Gross Margin of NLH (39.13%) is comparable to the rest of the industry.

In the last couple of years the Gross Margin of NLH has grown nicely.

		Industry Rank	Sector Rank
OM	3.04%
PM (TTM)	0.41%
GM	39.13%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-13.52%

PM growth 5YN/A

GM growth 3Y4.24%

GM growth 5Y2.71%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NLH is destroying value.

NLH has more shares outstanding than it did 1 year ago.

NLH has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, NLH has a worse debt to assets ratio.

2.2 Solvency

NLH has an Altman-Z score of 3.23. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 3.23, NLH belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.

NLH has a debt to FCF ratio of 2.32. This is a good value and a sign of high solvency as NLH would need 2.32 years to pay back of all of its debts.

The Debt to FCF ratio of NLH (2.32) is better than 86.67% of its industry peers.

A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.04, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	2.32
Altman-Z	3.23

ROIC/WACC0.44

WACC7.5%

2.3 Liquidity

NLH has a Current Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.

NLH has a Current ratio (0.82) which is in line with its industry peers.

NLH has a Quick Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.82, NLH perfoms like the industry average, outperforming 53.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.82
Quick Ratio	0.82

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.38%, which is quite good.

NLH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.19% yearly.

Looking at the last year, NLH shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.

Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.

EPS 1Y (TTM)15.38%

EPS 3Y-11.19%

EPS 5YN/A

EPS Q2Q%-311.54%

Revenue 1Y (TTM)8.63%

Revenue growth 3Y6.58%

Revenue growth 5Y8.16%

Sales Q2Q%26.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.

Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 80.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	11.69
EV/EBITDA	12

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NLH does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NOVA LEAP HEALTH CORP

TSX-V:NLH (10/21/2025, 7:00:00 PM)

0.265

-0.01 (-1.85%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-07 2025-08-07

Earnings (Next)11-06 2025-11-06

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners18.98%

Ins Owner ChangeN/A

Market Cap23.14M

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.59
P/FCF	11.69
P/OCF	11.48
P/B	0.88
P/tB	20.38
EV/EBITDA	12

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.02

FCFY8.56%

OCF(TTM)0.02

OCFY8.71%

SpS0.45

BVpS0.3

TBVpS0.01

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.49%
ROE	0.62%
ROCE	4.39%
ROIC	3.34%
ROICexc	3.59%
ROICexgc	267.42%
OM	3.04%
PM (TTM)	0.41%
GM	39.13%
FCFM	5.02%

ROA(3y)-0.79%

ROA(5y)2.27%

ROE(3y)-0.91%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-13.52%

PM growth 5YN/A

GM growth 3Y4.24%

GM growth 5Y2.71%

F-Score5

Asset Turnover1.19

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	2.32
Debt/EBITDA	0.53
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	5.13
Cash Conversion	92.26%
Profit Quality	1214.21%
Current Ratio	0.82
Quick Ratio	0.82
Altman-Z	3.23

F-Score5

WACC7.5%

ROIC/WACC0.44

Cap/Depr(3y)4.23%

Cap/Depr(5y)2.79%

Cap/Sales(3y)0.15%

Cap/Sales(5y)0.1%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15.38%

EPS 3Y-11.19%

EPS 5YN/A

EPS Q2Q%-311.54%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)8.63%

Revenue growth 3Y6.58%

Revenue growth 5Y8.16%

Sales Q2Q%26.55%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-11.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-37.27%

FCF growth 3Y-14.49%

FCF growth 5Y17.9%

OCF growth 1Y-37.45%

OCF growth 3Y-13.97%

OCF growth 5Y17.73%

NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens